Отчет об исследовании рынка магнитных шариков для сортировки клеток

Обзор рынка

Cell sorting magnetic beads are critical tools in biomedical research and cell therapy, with rapid market growth in recent years. The global magnetic beads market reached USD 3.89 миллиард в 2024 and is projected to exceed USD 16.01 миллиард на 2037, growing at a compound annual growth rate (Среднегодовой темп роста) из 11.5%. Cell sorting beads account for 10–15% of the total cost in CAR-T cell therapy production. Однако, над 95% of the market is dominated by international players like Miltenyi Biotec and Thermo Fisher, while Chinese domestic companies remain in the technological catch-up phase.  

Ключевые приложения

CAR-T Cell Therapy: Used for high-purity T-cell isolation, achieving over 99% CD3cell purity post-sorting (например, CD3cell ratio reduced from 36.5% к 0.7% in clinical cases).

Immunology Research: Sorting immune cells (B cells, NK cells) via antigen-specific magnetic labeling.

Stem Cell Therapy: Isolation of hematopoietic stem cells and mesenchymal stem cells for regenerative medicine.

In Vitro Diagnostics(ИВД): Rapid enrichment of circulating tumor cells (CTCs) or pathogens. Драйверы рынка  

Growth of Cell Therapy: Expanding CAR-T therapy commercialization drives demand, with magnetic beads constituting 10–15% of production costs.

Precision Medicine: High-purity cell isolation is essential for single-cell sequencing and personalized therapies.

Localization Trends: Chinese companies like GenScript offer GMP-grade CytoSinct™ beads at 20–30% lower prices than imports, supported by policies promoting domestic alternatives. Technology Advancements: Nano-sized beads (50–70 nm) with high antibody conjugation efficiency and superparamagnetic properties are mainstream.

Competitive Landscape

International Leaders: Miltenyi Biotec, Thermo Fisher, and BD control over 90% of the high-end market with end-to-end solutions.

Domestic Players: Companies like GenScript and Beaver Biosciences focus on cost-effective mid-to-low-end markets. GenScript’s beads are used in CAR-T clinical trials.

Technical Challenges: Key barriers include bead size uniformity, antibody conjugation efficiency, and batch consistency. Domestic firms face hurdles in scaling nano-bead production.

Перспективы на будущее

The cell sorting magnetic beads market is expected to grow at over 12% CAGR from 2025 к 2030, driven by cell and gene therapy expansion. Chinese companies may achieve over 30% import substitution in 3–5 years, particularly in GMP-grade bead production, supported by policies like the 14th Five-Year Plan for biopharma innovation.  

Поставщик

Шанхайская биотехнологическая компания Линцзюнь., ОООбыл создан в 2016 который является профессиональным производителем биомагнитных материалов и реагентов для экстракции нуклеиновых кислот..

Мы имеем богатый опыт в экстракции и очистке нуклеиновых кислот., очистка белка, разделение клеток, хемилюминесценция, и другие технические области.

Наша продукция широко используется во многих областях., например, медицинское тестирование, генетическое тестирование, университетские исследования, генетическое разведение, и так далее. Мы не только поставляем продукцию, но и можем взять на себя OEM, ОДМ, и другие потребности. Если у вас есть соответствующая потребность, пожалуйста, не стесняйтесь обращаться к нам .